<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> and insulin deficiency are proposed as risk factors for IGT and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We assessed the predictive value of initial parameters for the outcome of an OGTT performed 24.3+/-2.9 years later in an unselected healthy non-<z:mp ids='MP_0001261'>obese</z:mp> population </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The K-value of an IVGTT was determined in 267 healthy subjects (mean+/-SD: age 31.0+/-12.0 years, BMI 21.8+/-2.8 kg/m(2)) </plain></SENT>
<SENT sid="3" pm="."><plain>First-phase insulin response to a <z:chebi fb="105" ids="17234">glucose</z:chebi> infusion test was estimated as an incremental 5- or 10-min (DeltaI5 or DeltaI10) value, and as insulinogenic indices (DeltaI5/DeltaG5 or DeltaI10/DeltaG10) adjusted for insulin sensitivity determined by homeostasis model assessment for <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> ([DeltaI5/DeltaG5]/HOMA-IR) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: At follow-up, six subjects had type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and 47 had IGT; 214 retained <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
<SENT sid="5" pm="."><plain>Insulin sensitivity and early (30 min) insulin response decreased with decreasing outcome OGTT </plain></SENT>
<SENT sid="6" pm="."><plain>Blood <z:chebi fb="105" ids="17234">glucose</z:chebi> (2 h) at OGTT correlated positively with initial age and BMI, and negatively with DeltaI5/DeltaG5, (DeltaI5/DeltaG5)/HOMA-IR and K-value </plain></SENT>
<SENT sid="7" pm="."><plain>In multiple linear regression analysis, (DeltaI5/DeltaG5)/HOMA-IR, DeltaI10, K-value, age, HOMA estimate of insulin secretion, and fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> were significantly associated with 2-h OGTT blood <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Similar results were obtained on comparing differences between subjects with <z:mpath ids='MPATH_458'>normal</z:mpath> and decreased (IGT+<z:mp ids='MP_0002055'>diabetes</z:mp>) <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/INTERPRETATION: In 267 non-<z:mp ids='MP_0001261'>obese</z:mp> healthy subjects, initial K-value and first-phase insulin response to <z:chebi fb="105" ids="17234">glucose</z:chebi> adjusted for insulin sensitivity, but not insulin sensitivity itself, were strong predictors of the outcome of an OGTT performed 25 years later </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, in contrast to <z:mp ids='MP_0001261'>obese</z:mp> or other high-risk populations, in lean subjects, decreased beta cell function, but not <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> itself, determines future <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance </plain></SENT>
</text></document>